AVGO vs BLBD Stock Comparison

BLBD currently leads AVGO in this stock comparison, with AIQ scores of 64 vs 55. The clearest difference is value.

Market data as of Nov 22, 2026 market close· AIQ score gap 9 points
AVGO
Technology
vs
BLBD
Consumer Cyclical
AVGO
Broadcom Inc.
Price
$304
Day move
-12.19%
AIQ Score
55/100
Best edge
Balanced
Sector
Technology
BLBD
Blue Bird Corporation
Leads
Price
$56.49
Day move
-0.58%
AIQ Score
64/100
Best edge
Value
Sector
Consumer Cyclical

What is the main difference between AVGO and BLBD?

BLBD leads the current stock comparison as Blue Bird Corporation, with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs Blue Bird Corporation

Data as of Nov 22, 2026· market close· Cross-sector · Technology vs Consumer Cyclical· Coverage 62/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 7/10

BLBD leads

BLBD leads by 9 AIQ points, primarily on Value and Risk Resilience.

Stable: 4 of 5 evidence groups support BLBD.

Evidence agreement: 4 of 5Comparison trend: Stable
AVGO

Broadcom Inc.

AIQ Score
55/100
AIQ Edge Score
8/10
BLBD

Blue Bird Corporation

Leads
AIQ Score
64/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors BLBD over AVGO, 64 versus 55 as of Nov 22, 2026. BLBD's advantage is driven primarily by stronger value and risk resilience. BLBD also shows the stronger technical structure relative to its 50-day moving average. 4 of 5 covered evidence groups favor BLBD today, and the comparison is rated Stable on stability. BLBD lead: Stable — the AIQ differential has held near 9 points over 30 sessions.

Compare Broadcom Inc. and Blue Bird Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AVGO
+499.1%
BLBD
+143.5%

Total return comparison

Growth of $10,000, distributions reinvested

AVGO $59,905 · BLBD $24,349

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AVGO and BLBD against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
BLBD advantage
  • Value48 vs 65
    BLBD +17
  • Risk Resilience46 vs 63
    BLBD +17
  • Quality69 vs 76
    BLBD +7
  • Momentum51 vs 53
    Even

4 of 5 evidence groups favor BLBD. BLBD’s edge is concentrated in value and risk resilience.

What changed since the last close

Latest scored session 2026-11-20, compared against the prior scored session 2026-11-19.

AVGO-1 AIQ

Largest factor move: Momentum -3

New signals

  • TSI Bullish Crossover — bullish, momentum, short horizon
BLBD+1 AIQ

Largest factor move: Momentum +2

New signals

  • Downtrend Structure Active — bearish, trend, long horizon
  • Price Lost 50-Day MA — bearish, trend, medium horizon
  • RSI Midline Rejection — bearish, momentum, short horizon

BLBD's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — AVGO and BLBD both carry a full feed there.

The central trade-off

BLBD (Blue Bird Corporation): the stronger current systematic profile, led by value and risk resilience.

AVGO (Broadcom Inc.): the counter-case, on fundamentals — but at materially higher volatility, 71.4% against 47.5%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BLBD

BLBD on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AVGO

AVGO on combined revenue and EPS growth.

Value

BLBD

BLBD on the peer-relative Value factor, by 17 points.

Momentum

Even

The two are level on Momentum.

Lower downside

BLBD

BLBD on Risk Resilience, by 17 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureAVGOBLBDNote
Implied upside to target+69.3%—Level
Target dispersion+48.5%—Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering528Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 5 covered evidence groups favor BLBD. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBLBD55 vs 64
FundamentalsAVGOon balancerevenue growth 33.4% vs 46.7%; EPS growth 40.3% vs 4.9%; TTM ROE 13.1% vs 28.3%; gross margin 68.8% vs 20.6%; operating margin 48% vs 11.8% — AVGO takes 3 of 5 decided legs, not all of them
ValuationBLBDValue 48 vs 65
TechnicalsBLBDPrice vs 50-day -11.5% vs -1.9%; vs 200-day -5.8% vs -10.8%
Risk ResilienceBLBDRisk Resilience 46 vs 63
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and BLBD and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is moderate at 9 points.
  • 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BLBD.

How the comparison changed

120 daily snapshots · Jun 3 – Nov 20

BLBD lead: Stable — the AIQ differential has held near 9 points over 30 sessions.

Jun 3AVGO leads above the line · BLBD leads belowNov 20
Today
BLBD +9
55 vs 64
7 sessions ago
BLBD +9
52 vs 61
30 sessions ago
BLBD +8
52 vs 60
90 sessions ago
BLBD +9
55 vs 64

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only AVGO

  • Beta Spike Warning — bearish, risk_regime, long horizon
  • TSI Bullish Crossover — bullish, momentum, short horizon
BLBD

0 bullish / 4 bearish / 2 neutral

Only BLBD

  • Downtrend Structure Active — bearish, trend, long horizon
  • Price Lost 50-Day MA — bearish, trend, medium horizon
  • RSI Midline Rejection — bearish, momentum, short horizon

Both carry 3 more signals that do not separate them: Death Cross Active, ADX Trend Weakening, ATR Expansion - Breakout Mode.

AVGO is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGOConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -12.19%, AIQ -1 points).

BLBDDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.58%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AVGO closes the Value gap — currently 17 points behind, the largest single contributor to BLBD's edge.
  2. 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3BLBD starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricAVGOBLBD
Revenue growth (YoY)33.4%46.7%
EPS growth (YoY)40.3%4.9%
Gross margin68.8%20.6%
Operating margin48%11.8%
Return on equity (TTM)13.1%28.3%
Debt to equity0.60.18

Performance

BLBD leads 4 of 6 windows
MetricAVGOBLBD
1 week (5 sessions)-4.9%2.5%
1 month (20 sessions)7.2%0.2%
3 months (63 sessions)-5.9%-8.2%
6 months (126 sessions)-16.4%-12.3%
Year to date0.2%20.9%
1 year (252 sessions)1.8%12.9%

Technicals

BLBD has the stronger structure
MetricAVGOBLBD
RSI (14)52.648.8
ADX (14)19.318
Price vs 50-day-11.5%-1.9%
Price vs 200-day-5.8%-10.8%
Volatility (1M, annualized)71.4%47.5%

Risk

BLBD is the more resilient
MetricAVGOBLBD
Beta2.161.07
Sharpe ratio0.120.39
Sortino ratio0.170.55
Max drawdown-39.5%-33.7%
Current drawdown-28%-30.3%
Annualized volatility48.8%43.4%
Value at risk (95%)-4.6%-3.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or BLBD?

On the Algovestiq AIQ Score, BLBD is the stronger of the two as of Nov 22, 2026, scoring 64 against AVGO's 55. The edge comes from value and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or BLBD the better buy right now?

BLBD carries the stronger systematic profile as of Nov 22, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor BLBD over AVGO?

The composite weights Quality, Value, Momentum and Risk Resilience. BLBD leads Value by 17 points; BLBD leads Risk Resilience by 17 points; BLBD leads Quality by 7 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AVGO or BLBD?

Analyst price targets imply +69.3% upside for AVGO and not covered for BLBD. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or BLBD?

BLBD is the better-valued of the two on the peer-relative Value factor. BLBD on the peer-relative Value factor, by 17 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or BLBD?

AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or BLBD?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or BLBD?

BLBD is the more resilient of the two, so the other name carries the higher downside risk. BLBD on Risk Resilience, by 17 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than BLBD?

The profitability evidence is mixed: gross margin 68.8% vs 20.6%; operating margin 48% vs 11.8%; ttm roe 13.1% vs 28.3%. AVGO leads on two measures and BLBD on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is BLBD's lead over AVGO getting stronger or weaker?

BLBD lead: Stable — the AIQ differential has held near 9 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-03 and 2026-11-20. The lead has not changed hands in that window.

What would change the AVGO vs BLBD verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Value gap — currently 17 points behind, the largest single contributor to BLBD's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; BLBD starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AVGO and BLBD?

AVGO: 1 bullish / 2 bearish / 2 neutral, conflicted. BLBD: 0 bullish / 4 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On BLBD it is Death Cross Active (bearish, long horizon).

Compare AVGO and BLBD with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.